Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,838,116
+$1,423,429 QoQ
Shares Held
39,096
+1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#923
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $34,343,984 across 14 Drug Manufacturers - General names. ABBV ranks #2 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,231 | $9,872,508 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
39,096 | $9,838,116 | |
| 3 | JNJ |
Johnson & Johnson
|
18,662 | $4,739,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,933 | $3,075,390 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,985 | $2,019,544 | |
| 6 | AMGN |
Amgen Inc
|
2,893 | $1,047,612 | |
| 7 | PFE |
Pfizer Inc
|
41,679 | $1,003,629 | |
| 8 | NVS |
Novartis AG
|
4,509 | $706,649 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,838,116 | 39,096 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $8,414,687 | 38,690 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,662,741 | 37,913 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $8,822,136 | 38,102 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,421,709 | 34,596 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,659,841 | 36,559 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,917,587 | 33,301 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,246,489 | 31,631 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $5,503,562 | 32,087 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $5,793,329 | 31,814 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $5,026,296 | 32,434 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $4,979,796 | 33,408 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,524,907 | 33,585 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $5,369,015 | 33,689 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $5,698,045 | 35,258 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,658,831 | 34,713 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,246,036 | 34,252 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $5,699,139 | 35,156 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $5,403,272 | 39,906 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $6,776,069 | 62,817 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $5,628,733 | 49,971 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $5,004,525 | 46,244 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $3,339,222 | 31,164 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,644,604 | 30,193 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $2,928,316 | 29,826 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,279,985 | 29,925 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||